TLSA
Tiziana Life Sciences Ltd
NASDAQ · Healthcare · Biotechnology · GB
$1.02
+4.67%Leverage
- Debt / equity
- 8.77x
- Net debt / equity
- -68.35x
- Debt / assets
- 0.04x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.08x
Liquidity & coverage
- Current ratio
- 0.76x
- Quick ratio
- 0.76x
- Cash ratio
- 0.36x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$2.7M
Cash & dividend
- FCF / debt
- -30.93x
- Cash flow / debt
- -30.86x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025